» Articles » PMID: 15044746

Transjugular Intrahepatic Portosystemic Shunts: Long-term Patency and Clinical Results in a Patient Cohort Observed for 3-9 Years

Overview
Journal Radiology
Specialty Radiology
Date 2004 Mar 27
PMID 15044746
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To retrospectively assess the outcome of transjugular intrahepatic portosystemic shunt (TIPS) placement in a nonselected group of consecutive patients.

Materials And Methods: TIPS placement was attempted in 82 patients. Patients were followed up for at least 3 years according to a standard protocol that included repeated shunt evaluations. Fifty-four patients underwent TIPS placement for variceal bleeding, 24 for refractory ascites, and four for other indications. Recurrent bleeding, effect on ascites, long-term patency, development of encephalopathy, and survival and complication rates were evaluated with Kaplan-Meier survival analysis and Cox multivariate analysis.

Results: TIPS placement was successful in 75 patients (91%). Mean follow-up lasted 29.4 months. Primary patency was 22% and 12%, primary-assisted patency was 67% and 46%, and secondary patency was 91% and 91% at 1- and 5-year follow-up, respectively. Nonalcoholic liver disease (P =.007) and increasing platelet counts (P =.006) independently predicted development of shunt insufficiency. The 1- and 5-year rates of recurrent variceal bleeding were 21% and 27%, respectively. In the majority of patients with refractory ascites, a beneficial effect of TIPS placement was observed. The risk for encephalopathy was 25% at 1-month follow-up and 52% at 3-year follow-up. The risk for chronic or severe intermittent encephalopathy was 15% at 1-year follow-up and 20% at 3-year follow-up. Serum creatinine levels (P =.001) and age (P =.02) were independent risk factors. Overall survival rate was 61%, 49%, and 42% at 1-, 3-, and 5-year follow-up, respectively. Age (P =.03), serum albumin level (P =.02), and serum creatinine level (P <.001) were independently related to mortality.

Conclusion: The risk for definitive loss of shunt function was 17% at 5-year follow-up, indicating that surveillance with shunt revision-when indicated-results in excellent long-term TIPS patency. TIPS placement effectively protects against recurrent bleeding.

Citing Articles

Recurrent TIPS dysfunction and variceal bleeding: A combined, staged, use of large-bore aspiration thrombectomy and partial splenic artery embolization-A case report.

Kim D, Hong Y, Mirakhur A Radiol Case Rep. 2024; 20(1):352-356.

PMID: 39525906 PMC: 11550674. DOI: 10.1016/j.radcr.2024.10.003.


The Role of the Transjugular Intrahepatic Porto-Systemic Shunt in an Emergency Setting.

Posa A, Tenore L, Barbieri P, Mazza G, Sala E, Iezzi R Life (Basel). 2023; 13(4).

PMID: 37109397 PMC: 10146175. DOI: 10.3390/life13040868.


Portal cavernoma cholangiopathy: Update and recommendations on diagnosis and management.

Bhavsar R, Yadav A, Nundy S Ann Hepatobiliary Pancreat Surg. 2022; 26(4):298-307.

PMID: 36168271 PMC: 9721250. DOI: 10.14701/ahbps.22-029.


Combined transhepatic and transjugular approach for mechanical thrombectomy of massive TIPS thrombosis.

Newcomer J, Chishti E, Raissi D Radiol Case Rep. 2022; 17(5):1464-1469.

PMID: 35265241 PMC: 8899117. DOI: 10.1016/j.radcr.2022.01.086.


Comparison of embolic agents for varices during transjugular intrahepatic portosystemic shunt for variceal bleeding: Tissue gel or coil?.

Zhou L, Zhong B, Du H, Wang W, Shen J, Zhang S J Interv Med. 2021; 3(4):195-200.

PMID: 34805934 PMC: 8562183. DOI: 10.1016/j.jimed.2020.08.008.